Drug General Information
Drug ID
D05ACE
Former ID
DNC013973
Drug Name
1,5-bis(4-chlorophenyl)-1H-1,2,3-triazole
Drug Type
Small molecular drug
Indication Discovery agent Investigative [529882]
Structure
Download
2D MOL

3D MOL

Formula
C14H9Cl2N3
Canonical SMILES
C1=CC(=CC=C1C2=CN=NN2C3=CC=C(C=C3)Cl)Cl
InChI
1S/C14H9Cl2N3/c15-11-3-1-10(2-4-11)14-9-17-18-19(14)13-7-5-12(16)6-8-13/h1-9H
InChIKey
RXDUBIUDBWNEMF-UHFFFAOYSA-N
PubChem Compound ID
Target and Pathway
Target(s) Cannabinoid receptor 1 Target Info Inhibitor [529882]
KEGG Pathway Rap1 signaling pathway
Neuroactive ligand-receptor interaction
Retrograde endocannabinoid signaling
PANTHER Pathway Endogenous cannabinoid signaling
Pathway Interaction Database N-cadherin signaling events
Reactome Class A/1 (Rhodopsin-like receptors)
G alpha (i) signalling events
WikiPathways GPCRs, Class A Rhodopsin-like
Small Ligand GPCRs
BDNF signaling pathway
GPCR ligand binding
GPCR downstream signaling
GPCRs, Other
References
Ref 529882Bioorg Med Chem Lett. 2009 Feb 1;19(3):891-3. Epub 2008 Dec 6.Synthesis and CB1 cannabinoid receptor affinity of 4-alkoxycarbonyl-1,5-diaryl-1,2,3-triazoles.
Ref 529882Bioorg Med Chem Lett. 2009 Feb 1;19(3):891-3. Epub 2008 Dec 6.Synthesis and CB1 cannabinoid receptor affinity of 4-alkoxycarbonyl-1,5-diaryl-1,2,3-triazoles.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.